Literature DB >> 16420279

Corticosterone actions on the hippocampal brain-derived neurotrophic factor expression are mediated by exon IV promoter.

A C Hansson1, W H Sommer, M Metsis, I Strömberg, L F Agnati, K Fuxe.   

Abstract

Brain-derived neurotrophic factor (BDNF) expression is strongly regulated by adrenocorticosteroids via activated gluco- and mineralocorticoid receptors. Four separate promoters are located upstream of the BDNF noncoding exons I to IV and may thus be involved in adrenocorticosteroid-mediated gene regulation. In adrenalectomised rats, corticosterone (10 mg/kg s.c.) induces a robust down-regulation of both BDNF mRNA and protein levels in the hippocampus peaking at 2-8 h. To study the role of the individual promoters in the corticosterone response, we employed exon-specific riboprobe in situ hybridisation as well as real-time polymerase chain reaction (PCR) in the dentate gyrus. We found a down-regulation, mainly of exon IV and the protein-coding exon V, in nearby all hippocampal subregions, but exon II was only down-regulated in the dentate gyrus. Exon I and exon III transcripts were not affected by corticosterone treatment. The results could be confirmed with real-time PCR in the dentate gyrus. It appears as if the exon IV promoter is the major target for corticosterone-mediated transcriptional regulation of BDNF in the hippocampus.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16420279     DOI: 10.1111/j.1365-2826.2005.01390.x

Source DB:  PubMed          Journal:  J Neuroendocrinol        ISSN: 0953-8194            Impact factor:   3.627


  36 in total

1.  Heightening of the stress response during the first weeks after a mild traumatic brain injury.

Authors:  G S Griesbach; D A Hovda; D L Tio; A N Taylor
Journal:  Neuroscience       Date:  2011-01-26       Impact factor: 3.590

2.  Prenatal stress differentially alters brain-derived neurotrophic factor expression and signaling across rat strains.

Authors:  E W Neeley; R Berger; J I Koenig; S Leonard
Journal:  Neuroscience       Date:  2011-04-07       Impact factor: 3.590

Review 3.  Central effects of stress hormones in health and disease: Understanding the protective and damaging effects of stress and stress mediators.

Authors:  Bruce S McEwen
Journal:  Eur J Pharmacol       Date:  2008-01-30       Impact factor: 4.432

Review 4.  Central role of the brain in stress and adaptation: links to socioeconomic status, health, and disease.

Authors:  Bruce S McEwen; Peter J Gianaros
Journal:  Ann N Y Acad Sci       Date:  2010-02       Impact factor: 5.691

5.  BDNF protein expression in the hippocampus following exposure of rats to forced swimming stress.

Authors:  V V Bulygina; G T Shishkina; I V Berezova; N N Dygalo
Journal:  Dokl Biol Sci       Date:  2011-05-12

6.  Effects of acute restraint-induced stress on glucocorticoid receptors and brain-derived neurotrophic factor after mild traumatic brain injury.

Authors:  G S Griesbach; J Vincelli; D L Tio; D A Hovda
Journal:  Neuroscience       Date:  2012-03-15       Impact factor: 3.590

Review 7.  Are BDNF and glucocorticoid activities calibrated?

Authors:  F Jeanneteau; M V Chao
Journal:  Neuroscience       Date:  2012-09-26       Impact factor: 3.590

8.  Etazolate, a phosphodiesterase-4 enzyme inhibitor produces antidepressant-like effects by blocking the behavioral, biochemical, neurobiological deficits and histological abnormalities in hippocampus region caused by olfactory bulbectomy.

Authors:  Ankur Jindal; Radhakrishnan Mahesh; Shvetank Bhatt
Journal:  Psychopharmacology (Berl)       Date:  2014-08-15       Impact factor: 4.530

Review 9.  The pathophysiology of concussions in youth.

Authors:  Daniel W Shrey; Grace S Griesbach; Christopher C Giza
Journal:  Phys Med Rehabil Clin N Am       Date:  2011-09-25       Impact factor: 1.784

Review 10.  Activity-dependent, stress-responsive BDNF signaling and the quest for optimal brain health and resilience throughout the lifespan.

Authors:  S M Rothman; M P Mattson
Journal:  Neuroscience       Date:  2012-10-16       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.